1 / 1

QUANTITATING THE IMPACT OF CLINICAL AND BASIC SCIENCE RESEARCH POSTER #2469

QUANTITATING THE IMPACT OF CLINICAL AND BASIC SCIENCE RESEARCH POSTER #2469. M. O. GORDON, C. SARLI, E. K. DUBINSKY, E. LONG, C. LA RUE, M. A. KASS, AND THE OCULAR HYPERTENSION TREATMENT STUDY (OHTS) GROUP.

hope
Download Presentation

QUANTITATING THE IMPACT OF CLINICAL AND BASIC SCIENCE RESEARCH POSTER #2469

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. QUANTITATING THE IMPACT OF CLINICAL AND BASIC SCIENCE RESEARCH POSTER #2469 M. O. GORDON, C. SARLI, E. K. DUBINSKY, E. LONG, C. LA RUE, M. A. KASS, AND THE OCULAR HYPERTENSION TREATMENT STUDY (OHTS) GROUP OPHTHALMOLOGY AND VISUAL SCIENCES, BECKER MEDICAL LIBRARY, WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, ST. LOUIS, MISSOURI PURPOSE:To quantitate the impact of biomedical research on generation of new knowledge and change in clinical practice. Governments world-wide are demanding quantifiable outcome measures of research impact. METHODS FOR DOCUMENTING IMPACT CONCLUSION OHTS demonstrates that citation counts alone are inadequate to assess research impact. Impact should also include research output, knowledge transfer, and clinical implementation. To help document research impact, an interactive website was developed: Assessing the Impact of Research. (http://becker.wustl.edu/impact/assessment/index.html). Documentation of research impact will be a useful tool for progress reports, grant applications, and promotion dossiers. References: Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP, Parrish RK, Wilson MR, Gordon MO for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open angle glaucoma. Arch Ophthalmol 2002; 120:701-713. Kymes SM, Kass MA, Anderson DR, Miller JP, Gordon MO, and the Ocular Hypertension Treatment Study (OHTS) Group. Management of ocular hypertension: A cost-effectiveness approach from the Ocular Hypertension Treatment Study. Am J Ophthalmol 2006;141:997-1008. The Ocular Hypertension Treatment Study (OHTS) Group and the European Glaucoma Prevention Study (EGPS) Group. A validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology 2007;114:10-19. SUPPORT Support: NIH Grants EY 09307, EY 09341, EY015498, National Center on Minority Health and Health Disparities, UL1 RR024992 of the National Center for Research Resources, Horncrest Foundation, Merck Research Laboratories, and Pfizer, Inc. This work was also supported by awards to the Department of Ophthalmology and Visual Sciences, Washington University from a Research to Prevent Blindness, Inc. Unrestricted grant, and the NIH Vision Core Grant P30 EY 02687

More Related